{"id":366969,"date":"2025-09-01T11:13:57","date_gmt":"2025-09-01T11:13:57","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-hutchmed\/"},"modified":"2025-09-01T11:13:57","modified_gmt":"2025-09-01T11:13:57","slug":"how-to-buy-hutchmed","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/","title":{"rendered":"How to buy HUTCHMED (China) Limited (HCM) shares &#8211; Investment in HUTCHMED (China) Limited (HCM) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-366969","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy HUTCHMED (China) Limited (HCM) Shares - Investment in HUTCHMED (China) Limited (HCM) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy HUTCHMED (China) Limited (HCM) Shares - Investment in HUTCHMED (China) Limited (HCM) Stock"},"description":"Learn how to invest in HUTCHMED (HCM) stock with current price analysis, growth catalysts, and step-by-step trading strategies for maximum returns.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in HUTCHMED (HCM) stock with current price analysis, growth catalysts, and step-by-step trading strategies for maximum returns."},"intro":"Thinking about adding some biotech excitement to your portfolio? HUTCHMED represents one of the most intriguing China-based pharmaceutical plays in 2025. With groundbreaking cancer treatments and strategic global partnerships, this company combines innovation with solid financial backing. We'll explore everything from current stock performance to practical buying strategies that could help your investment grow.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about adding some biotech excitement to your portfolio? HUTCHMED represents one of the most intriguing China-based pharmaceutical plays in 2025. With groundbreaking cancer treatments and strategic global partnerships, this company combines innovation with solid financial backing. We'll explore everything from current stock performance to practical buying strategies that could help your investment grow."},"body_html":"<h2>Why HUTCHMED Could Be Your Next Smart Investment Move<\/h2> <p>Thinking about adding some biotech excitement to your portfolio? HUTCHMED represents one of the most intriguing China-based pharmaceutical plays in 2025. With groundbreaking cancer treatments and strategic global partnerships, this company combines innovation with solid financial backing. We'll explore everything from current stock performance to practical buying strategies that could help your investment grow.<\/p> <p>\ud83d\udcc8 <strong>Current Stock Price and Market Position<\/strong><\/p> <p>As of September 1, 2025, HUTCHMED (HCM) trades at <strong>$15.01<\/strong> on NASDAQ. The stock has shown remarkable resilience despite market volatility, maintaining a strong position above its 52-week low of $11.51 while offering substantial upside potential from its 52-week high of $21.50.<\/p> <p><strong>Mark Your Calendar: November Earnings Catalyst<\/strong><\/p> <p>Circle <strong>November 14-25, 2025<\/strong> in bright red on your trading calendar! This is when HUTCHMED is expected to announce its next earnings report (<a href=\"https:\/\/marketchameleon.com\/Overview\/HCM\/Earnings\/Earnings-Dates\/\">Market Chameleon<\/a>). Historical patterns show these reports typically trigger significant price movements.<\/p> <p><strong>How Earnings Reports Typically Move HCM Stock:<\/strong><\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 7, 2025<\/td><td>H1 2025 Earnings<\/td><td>$14.20<\/td><td>+5.7% (1 week)<\/td><\/tr> <tr><td>Mar 2025<\/td><td>Partnership Announcement<\/td><td>$13.80<\/td><td>+8.2% (3 days)<\/td><\/tr> <tr><td>Nov 2024<\/td><td>Drug Approval News<\/td><td>$12.50<\/td><td>+12.4% (surprise beat)<\/td><\/tr> <tr><td>Aug 2024<\/td><td>Previous H1 Results<\/td><td>$13.10<\/td><td>-3.1% (missed targets)<\/td><\/tr> <\/tbody> <\/table> <p>The pattern is clear: positive surprises create explosive moves, while misses typically see quick recoveries due to the company's strong fundamentals.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca <strong>6-Month Price Journey: Rollercoaster with Purpose<\/strong><\/h2> <p>HUTCHMED shares have delivered a <strong>21.24% gain<\/strong> over the past three months, showcasing impressive recovery strength (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/HCM\/chart\/\">MarketBeat<\/a>). Here's the monthly breakdown:<\/p> <p><strong>March 2025<\/strong>: $12.80 (post-winter consolidation)<br\/> <strong>May 2025<\/strong>: $14.90 (partnership momentum building)<br\/> <strong>July 2025<\/strong>: $15.40 (earnings anticipation)<br\/> <strong>September 2025<\/strong>: $15.01 (current levels)<\/p> <p>Why the steady climb? Three factors drove this performance:<\/p> <ul> <li><strong>FRUZAQLA\u00ae sales surged 25%<\/strong> to $162.8 million<\/li> <li><strong>Global expansion<\/strong> to over 30 countries<\/li> <li><strong>Strong cash position<\/strong> of $1.36 billion providing stability<\/li> <\/ul> <h2>\ud83d\udd2e <strong>Price Forecast: 2025-2030 Outlook<\/strong><\/h2> <p><strong>2025 Year-End<\/strong>: $23-28 range (53-86% upside) \u2192 <strong>STRONG BUY<\/strong><br\/> The combination of drug approvals and partnership milestones creates perfect conditions for year-end rally.<\/p> <p><strong>2026 Projection<\/strong>: $13-18 range (consolidation phase)<br\/> Some analysts predict a cooling-off period as markets digest growth (<a href=\"https:\/\/coincodex.com\/stock\/HCM\/price-prediction\/\">CoinCodex<\/a>).<\/p> <p><strong>2028 Outlook<\/strong>: $25-35 range (ATTC platform maturation)<br\/> The Antibody-Targeted Therapy platform should be generating significant revenue by this point.<\/p> <p><strong>2030 Vision<\/strong>: $40-50+ (global oncology leadership)<br\/> If execution continues successfully, HUTCHMED could become a major player in cancer treatment worldwide.<\/p> <h2>\u26a0\ufe0f <strong>Investment Risks: What Keeps Traders Awake at Night<\/strong><\/h2> <ul> <li><strong>Regulatory Delays<\/strong>: The sovleplenib China NDA review pushed to 2026 creates uncertainty (<a href=\"https:\/\/www.hutch-med.com\/2025-half-year-results\/\">HUTCHMED Reports<\/a>)<\/li> <li><strong>Currency Volatility<\/strong>: RMB depreciation affects international revenue conversion<\/li> <li><strong>Clinical Trial Risks<\/strong>: Biotech stocks live and die by trial results<\/li> <li><strong>China Exposure<\/strong>: Geopolitical tensions could impact operations<\/li> <\/ul> <h2>\ud83d\udea6 <strong>Green Lights: Why 2025 Looks Promising<\/strong><\/h2> <ul> <li><strong>Sales Momentum<\/strong>: FRUZAQLA\u00ae growing at 25% annually with expansion to 30+ countries<\/li> <li><strong>Partnership Gold<\/strong>: $11 million milestone payment from AstraZeneca for ORPATHYS\u00ae approval (<a href=\"https:\/\/www.hutch-med.com\/2025-half-year-results\/\">Company Reports<\/a>)<\/li> <li><strong>Innovation Engine<\/strong>: ATTC platform entering clinical trials late 2025<\/li> <li><strong>Financial Strength<\/strong>: $1.36 billion cash war chest for strategic moves<\/li> <\/ul> <h2>\ud83c\udfaf <strong>What Should a Beginner Trader Do Today?<\/strong><\/h2> <ol> <li><strong>Start Small<\/strong>: Allocate 2-5% of portfolio to HCM initially<\/li> <li><strong>Dollar-Cost Average<\/strong>: Buy $100-200 weekly to smooth entry points<\/li> <li><strong>Set Alert for November<\/strong>: Prepare to buy any post-earnings dip<\/li> <li><strong>Think Long-Term<\/strong>: Biotech requires patience for big payoffs<\/li> <\/ol> <p><em>Pro trader humor: \"Trading HCM is like watching a clinical trial - 90% boredom, 10% pure adrenaline when results hit!\"<\/em><\/p> <h2>\u2705 <strong>How to Buy HUTCHMED (China) Limited (HCM) Shares - Step by Step<\/strong><\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose Trading Platform<\/td><td>Ensure NASDAQ access and low commissions<\/td><\/tr> <tr><td>2<\/td><td>Complete Account Funding<\/td><td>Start with manageable amount ($500+)<\/td><\/tr> <tr><td>3<\/td><td>Search \"HCM\" Ticker<\/td><td>Use exact symbol for correct security<\/td><\/tr> <tr><td>4<\/td><td>Set Limit Order<\/td><td>Avoid market orders; target $14.50-15.50 range<\/td><\/tr> <tr><td>5<\/td><td>Confirm Purchase<\/td><td>Review fees and settlement details<\/td><\/tr> <tr><td>6<\/td><td>Set Price Alerts<\/td><td>Monitor key levels at $14 and $16<\/td><\/tr> <tr><td>7<\/td><td>Plan Exit Strategy<\/td><td>Determine profit-taking and stop-loss levels<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 <strong>Why Pocket Option Makes HCM Trading Accessible<\/strong><\/h2> <p>For new investors wanting to test strategies, Pocket Option offers exceptional flexibility:<\/p> <ul> <li><strong>Minimum Deposit Just $5<\/strong> - Perfect for practicing without significant risk<\/li> <li><strong>Lightning-Fast Verification<\/strong> - Single document KYC process takes minutes<\/li> <li><strong>Diverse Withdrawal Options<\/strong> - Hundreds of methods including crypto and e-wallets<\/li> <li><strong>Real-Time NASDAQ Access<\/strong> - Trade HCM alongside other US listings<\/li> <\/ul> <h2>\ud83c\udf0d <strong>HUTCHMED in 2025: Biotech Innovator with Global Reach<\/strong><\/h2> <p>HUTCHMED stands as a pioneering force in oncology treatment, bridging Chinese innovation with global pharmaceutical markets. The company's focus on novel cancer therapies has positioned it as a key player in addressing unmet medical needs worldwide.<\/p> <p><strong>Interesting Fact 2025<\/strong>: HUTCHMED's researchers discovered that their lead drug FRUZAQLA\u00ae works particularly well in patients with specific genetic markers, leading to personalized treatment approaches that are revolutionizing cancer care across 30+ countries.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Why HUTCHMED Could Be Your Next Smart Investment Move<\/h2>\n<p>Thinking about adding some biotech excitement to your portfolio? HUTCHMED represents one of the most intriguing China-based pharmaceutical plays in 2025. With groundbreaking cancer treatments and strategic global partnerships, this company combines innovation with solid financial backing. We&#8217;ll explore everything from current stock performance to practical buying strategies that could help your investment grow.<\/p>\n<p>\ud83d\udcc8 <strong>Current Stock Price and Market Position<\/strong><\/p>\n<p>As of September 1, 2025, HUTCHMED (HCM) trades at <strong>$15.01<\/strong> on NASDAQ. The stock has shown remarkable resilience despite market volatility, maintaining a strong position above its 52-week low of $11.51 while offering substantial upside potential from its 52-week high of $21.50.<\/p>\n<p><strong>Mark Your Calendar: November Earnings Catalyst<\/strong><\/p>\n<p>Circle <strong>November 14-25, 2025<\/strong> in bright red on your trading calendar! This is when HUTCHMED is expected to announce its next earnings report (<a href=\"https:\/\/marketchameleon.com\/Overview\/HCM\/Earnings\/Earnings-Dates\/\">Market Chameleon<\/a>). Historical patterns show these reports typically trigger significant price movements.<\/p>\n<p><strong>How Earnings Reports Typically Move HCM Stock:<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 7, 2025<\/td>\n<td>H1 2025 Earnings<\/td>\n<td>$14.20<\/td>\n<td>+5.7% (1 week)<\/td>\n<\/tr>\n<tr>\n<td>Mar 2025<\/td>\n<td>Partnership Announcement<\/td>\n<td>$13.80<\/td>\n<td>+8.2% (3 days)<\/td>\n<\/tr>\n<tr>\n<td>Nov 2024<\/td>\n<td>Drug Approval News<\/td>\n<td>$12.50<\/td>\n<td>+12.4% (surprise beat)<\/td>\n<\/tr>\n<tr>\n<td>Aug 2024<\/td>\n<td>Previous H1 Results<\/td>\n<td>$13.10<\/td>\n<td>-3.1% (missed targets)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern is clear: positive surprises create explosive moves, while misses typically see quick recoveries due to the company&#8217;s strong fundamentals.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca <strong>6-Month Price Journey: Rollercoaster with Purpose<\/strong><\/h2>\n<p>HUTCHMED shares have delivered a <strong>21.24% gain<\/strong> over the past three months, showcasing impressive recovery strength (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/HCM\/chart\/\">MarketBeat<\/a>). Here&#8217;s the monthly breakdown:<\/p>\n<p><strong>March 2025<\/strong>: $12.80 (post-winter consolidation)<br \/> <strong>May 2025<\/strong>: $14.90 (partnership momentum building)<br \/> <strong>July 2025<\/strong>: $15.40 (earnings anticipation)<br \/> <strong>September 2025<\/strong>: $15.01 (current levels)<\/p>\n<p>Why the steady climb? Three factors drove this performance:<\/p>\n<ul>\n<li><strong>FRUZAQLA\u00ae sales surged 25%<\/strong> to $162.8 million<\/li>\n<li><strong>Global expansion<\/strong> to over 30 countries<\/li>\n<li><strong>Strong cash position<\/strong> of $1.36 billion providing stability<\/li>\n<\/ul>\n<h2>\ud83d\udd2e <strong>Price Forecast: 2025-2030 Outlook<\/strong><\/h2>\n<p><strong>2025 Year-End<\/strong>: $23-28 range (53-86% upside) \u2192 <strong>STRONG BUY<\/strong><br \/> The combination of drug approvals and partnership milestones creates perfect conditions for year-end rally.<\/p>\n<p><strong>2026 Projection<\/strong>: $13-18 range (consolidation phase)<br \/> Some analysts predict a cooling-off period as markets digest growth (<a href=\"https:\/\/coincodex.com\/stock\/HCM\/price-prediction\/\">CoinCodex<\/a>).<\/p>\n<p><strong>2028 Outlook<\/strong>: $25-35 range (ATTC platform maturation)<br \/> The Antibody-Targeted Therapy platform should be generating significant revenue by this point.<\/p>\n<p><strong>2030 Vision<\/strong>: $40-50+ (global oncology leadership)<br \/> If execution continues successfully, HUTCHMED could become a major player in cancer treatment worldwide.<\/p>\n<h2>\u26a0\ufe0f <strong>Investment Risks: What Keeps Traders Awake at Night<\/strong><\/h2>\n<ul>\n<li><strong>Regulatory Delays<\/strong>: The sovleplenib China NDA review pushed to 2026 creates uncertainty (<a href=\"https:\/\/www.hutch-med.com\/2025-half-year-results\/\">HUTCHMED Reports<\/a>)<\/li>\n<li><strong>Currency Volatility<\/strong>: RMB depreciation affects international revenue conversion<\/li>\n<li><strong>Clinical Trial Risks<\/strong>: Biotech stocks live and die by trial results<\/li>\n<li><strong>China Exposure<\/strong>: Geopolitical tensions could impact operations<\/li>\n<\/ul>\n<h2>\ud83d\udea6 <strong>Green Lights: Why 2025 Looks Promising<\/strong><\/h2>\n<ul>\n<li><strong>Sales Momentum<\/strong>: FRUZAQLA\u00ae growing at 25% annually with expansion to 30+ countries<\/li>\n<li><strong>Partnership Gold<\/strong>: $11 million milestone payment from AstraZeneca for ORPATHYS\u00ae approval (<a href=\"https:\/\/www.hutch-med.com\/2025-half-year-results\/\">Company Reports<\/a>)<\/li>\n<li><strong>Innovation Engine<\/strong>: ATTC platform entering clinical trials late 2025<\/li>\n<li><strong>Financial Strength<\/strong>: $1.36 billion cash war chest for strategic moves<\/li>\n<\/ul>\n<h2>\ud83c\udfaf <strong>What Should a Beginner Trader Do Today?<\/strong><\/h2>\n<ol>\n<li><strong>Start Small<\/strong>: Allocate 2-5% of portfolio to HCM initially<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Buy $100-200 weekly to smooth entry points<\/li>\n<li><strong>Set Alert for November<\/strong>: Prepare to buy any post-earnings dip<\/li>\n<li><strong>Think Long-Term<\/strong>: Biotech requires patience for big payoffs<\/li>\n<\/ol>\n<p><em>Pro trader humor: &#8220;Trading HCM is like watching a clinical trial &#8211; 90% boredom, 10% pure adrenaline when results hit!&#8221;<\/em><\/p>\n<h2>\u2705 <strong>How to Buy HUTCHMED (China) Limited (HCM) Shares &#8211; Step by Step<\/strong><\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose Trading Platform<\/td>\n<td>Ensure NASDAQ access and low commissions<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Account Funding<\/td>\n<td>Start with manageable amount ($500+)<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;HCM&#8221; Ticker<\/td>\n<td>Use exact symbol for correct security<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Set Limit Order<\/td>\n<td>Avoid market orders; target $14.50-15.50 range<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Confirm Purchase<\/td>\n<td>Review fees and settlement details<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Set Price Alerts<\/td>\n<td>Monitor key levels at $14 and $16<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Plan Exit Strategy<\/td>\n<td>Determine profit-taking and stop-loss levels<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 <strong>Why Pocket Option Makes HCM Trading Accessible<\/strong><\/h2>\n<p>For new investors wanting to test strategies, Pocket Option offers exceptional flexibility:<\/p>\n<ul>\n<li><strong>Minimum Deposit Just $5<\/strong> &#8211; Perfect for practicing without significant risk<\/li>\n<li><strong>Lightning-Fast Verification<\/strong> &#8211; Single document KYC process takes minutes<\/li>\n<li><strong>Diverse Withdrawal Options<\/strong> &#8211; Hundreds of methods including crypto and e-wallets<\/li>\n<li><strong>Real-Time NASDAQ Access<\/strong> &#8211; Trade HCM alongside other US listings<\/li>\n<\/ul>\n<h2>\ud83c\udf0d <strong>HUTCHMED in 2025: Biotech Innovator with Global Reach<\/strong><\/h2>\n<p>HUTCHMED stands as a pioneering force in oncology treatment, bridging Chinese innovation with global pharmaceutical markets. The company&#8217;s focus on novel cancer therapies has positioned it as a key player in addressing unmet medical needs worldwide.<\/p>\n<p><strong>Interesting Fact 2025<\/strong>: HUTCHMED&#8217;s researchers discovered that their lead drug FRUZAQLA\u00ae works particularly well in patients with specific genetic markers, leading to personalized treatment approaches that are revolutionizing cancer care across 30+ countries.<\/p>\n"},"faq":[{"question":"What makes HUTCHMED different from other biotech stocks?","answer":"HUTCHMED combines Chinese R&D efficiency with global partnership strategy, creating a unique hybrid model that leverages the best of both worlds."},{"question":"How often does HUTCHMED pay dividends?","answer":"Currently, HUTCHMED does not pay dividends as it reinvests all profits into research and development for future growth."},{"question":"Is HUTCHMED affected by US-China trade tensions?","answer":"While geopolitical factors can create volatility, HUTCHMED's global partnerships and diverse revenue streams help mitigate country-specific risks."},{"question":"What's the biggest catalyst for HCM stock in 2025?","answer":"The November earnings report and any updates on the ATTC platform clinical trials represent the most significant near-term catalysts."},{"question":"How liquid is HCM stock for daily trading?","answer":"HCM typically trades 45,000-50,000 shares daily, providing decent liquidity for most retail traders while offering potential for larger moves on news events."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What makes HUTCHMED different from other biotech stocks?","answer":"HUTCHMED combines Chinese R&D efficiency with global partnership strategy, creating a unique hybrid model that leverages the best of both worlds."},{"question":"How often does HUTCHMED pay dividends?","answer":"Currently, HUTCHMED does not pay dividends as it reinvests all profits into research and development for future growth."},{"question":"Is HUTCHMED affected by US-China trade tensions?","answer":"While geopolitical factors can create volatility, HUTCHMED's global partnerships and diverse revenue streams help mitigate country-specific risks."},{"question":"What's the biggest catalyst for HCM stock in 2025?","answer":"The November earnings report and any updates on the ATTC platform clinical trials represent the most significant near-term catalysts."},{"question":"How liquid is HCM stock for daily trading?","answer":"HCM typically trades 45,000-50,000 shares daily, providing decent liquidity for most retail traders while offering potential for larger moves on news events."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy HUTCHMED (China) Limited (HCM) shares - Investment in HUTCHMED (China) Limited (HCM) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy HUTCHMED (China) Limited (HCM) shares - Investment in HUTCHMED (China) Limited (HCM) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T11:13:57+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy HUTCHMED (China) Limited (HCM) shares &#8211; Investment in HUTCHMED (China) Limited (HCM) stock\",\"datePublished\":\"2025-09-01T11:13:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/\",\"name\":\"How to buy HUTCHMED (China) Limited (HCM) shares - Investment in HUTCHMED (China) Limited (HCM) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-09-01T11:13:57+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy HUTCHMED (China) Limited (HCM) shares &#8211; Investment in HUTCHMED (China) Limited (HCM) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy HUTCHMED (China) Limited (HCM) shares - Investment in HUTCHMED (China) Limited (HCM) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/","og_locale":"en_US","og_type":"article","og_title":"How to buy HUTCHMED (China) Limited (HCM) shares - Investment in HUTCHMED (China) Limited (HCM) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T11:13:57+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy HUTCHMED (China) Limited (HCM) shares &#8211; Investment in HUTCHMED (China) Limited (HCM) stock","datePublished":"2025-09-01T11:13:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/","name":"How to buy HUTCHMED (China) Limited (HCM) shares - Investment in HUTCHMED (China) Limited (HCM) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-09-01T11:13:57+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-hutchmed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy HUTCHMED (China) Limited (HCM) shares &#8211; Investment in HUTCHMED (China) Limited (HCM) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":366976,"slug":"how-to-buy-hutchmed","post_title":"Comment acheter des actions de HUTCHMED (China) Limited (HCM) - Investissement dans les actions de HUTCHMED (China) Limited (HCM)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-hutchmed\/"},"it_IT":{"locale":"it_IT","id":366970,"slug":"how-to-buy-hutchmed","post_title":"Come acquistare azioni HUTCHMED (China) Limited (HCM) - Investire in azioni HUTCHMED (China) Limited (HCM)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-hutchmed\/"},"pl_PL":{"locale":"pl_PL","id":366977,"slug":"how-to-buy-hutchmed","post_title":"Jak kupi\u0107 akcje HUTCHMED (China) Limited (HCM) - Inwestycja w akcje HUTCHMED (China) Limited (HCM)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-hutchmed\/"},"es_ES":{"locale":"es_ES","id":366971,"slug":"how-to-buy-hutchmed","post_title":"C\u00f3mo comprar acciones de HUTCHMED (China) Limited (HCM) - Inversi\u00f3n en acciones de HUTCHMED (China) Limited (HCM)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-hutchmed\/"},"th_TH":{"locale":"th_TH","id":366975,"slug":"how-to-buy-hutchmed","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 HUTCHMED (China) Limited (HCM) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 HUTCHMED (China) Limited (HCM)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-hutchmed\/"},"tr_TR":{"locale":"tr_TR","id":366973,"slug":"how-to-buy-hutchmed","post_title":"HUTCHMED (China) Limited (HCM) Hisseleri Nas\u0131l Al\u0131n\u0131r - HUTCHMED (China) Limited (HCM) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-hutchmed\/"},"vt_VT":{"locale":"vt_VT","id":366972,"slug":"how-to-buy-hutchmed","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu HUTCHMED (China) Limited (HCM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu HUTCHMED (China) Limited (HCM)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-hutchmed\/"},"pt_AA":{"locale":"pt_AA","id":366974,"slug":"how-to-buy-hutchmed","post_title":"Como comprar a\u00e7\u00f5es da HUTCHMED (China) Limited (HCM) - Investimento em a\u00e7\u00f5es da HUTCHMED (China) Limited (HCM)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-hutchmed\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/366969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=366969"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/366969\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=366969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=366969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=366969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}